The American Journal of Medicine
Volume 113, Issue 7 , Pages 580-586 , November 2002

Peripheral edema

  • Shaun Cho, MD

      Affiliations

    • Division of Cardiovascular Medicine, Department of Internal Medicine, Stanford University Medical Center, and Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA
    • ,
  • J.Edwin Atwood, MD

      Affiliations

    • Division of Cardiovascular Medicine, Department of Internal Medicine, Stanford University Medical Center, and Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA
    • Corresponding Author InformationRequests for reprints should be addressed to J. Edwin Atwood, MD, Department of Cardiology, Building 2, Walter Reed Army Center, 6900 Georgia NW, Washington, D.C. 20307 USA

Received 13 March 2002 ,Revised 13 May 2002 ,Accepted 5 August 2002.

References 

  1. Braunwald E. Edema. In:  Isselbacher KJ,  Braunwald E,  Wilson JD, et al. editor. Harrison’s Principles of Internal Medicine. 13th ed. New York: McGraw-Hill; 1994;p. 183–187
  2. Starling EH. Physiologic forces involved in the causation of dropsy. Lancet. 1896;I:1267–1270
  3. Little RC, Ginsburg JM. The physiologic basis for clinical edema. Arch Intern Med. 1984;144:1661–1664
  4. Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders. New York: McGraw-Hill; 2001;
  5. Andreoli TE. Edematous states (an overview). Kidney Int. 1997;51(suppl):S2–S10
  6. Rose BD. Renal Pathophysiology (The Essentials). Baltimore: Williams & Wilkins; 1994;
  7. Diskin CJ, Stokes TJ, Dansby LM, et al.  Towards an understanding of oedema. BMJ. 1999;318:1610–1613
  8. Townsend JN, Doran J, Lote CJ, Davies MK. Peripheral hemodynamic effect of inhibition of prostaglandins synthesis in congestive heart failure and interactions with captopril. Br Heart J. 1995;73:434–441
  9. Martin PY, Schrier RW. Sodium and water retention in heart failure (pathogenesis and treatment). Kidney Int. 1997;51(suppl):S57–S61
  10. Anand IS, Ferrari R, Gurcharan SK, et al.  Edema of cardiac origin (studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive failure). Circulation. 1989;80:299–305
  11. Anand IS, Ferrari R, Kalra GS, et al.  Pathogenesis of edema in constrictive pericarditis. Circulation. 1991;83:1880–1887
  12. Ritz E, Stefanski A. Diabetic nephropathy in type II diabetes. Am J Kidney Dis. 1996;27:167–194
  13. Dorhout Mees EJ, Geers AB, Koomans HA. Blood volume and sodium retention in the nephrotic syndrome (a controversial pathophysiological concept). Nephron. 1984;36:201–211
  14. Eisenberg S. Blood volume in persons with the nephrotic syndrome. Am J Med Sci. 1968;255:320–326
  15. Chonko AM, Bay WH, Stein J, et al.  The role of renin and aldosterone in the salt retention of edema. Am J Med. 1977;63:881–889
  16. Palmer BF, Alpern RJ. Pathogenesis of edema formation in the nephrotic syndrome. Kidney Int. 1997;51(suppl):S21–S27
  17. Martin PY, Schrier RW. Pathogenesis of water and sodium retention in cirrhosis. Kidney Int. 1997;51(suppl):S43–S49
  18. Halperin AK, Cubeddu LX. The role of calcium channel blockers in the treatment of hypertension. Am Heart J. 1986;111:363–382
  19. Andresdottir MB, van Hamersvelt HW, van Helden MJ, et al.  Ankle edema formation during treatment with the calcium channel blockers lacidipine and amlodipine (a single-centre study). J Card Pharm. 2000;35(suppl):S25–S30
  20. Valentin JP, Ribstein J, Halimi JM, Mimran A. Effect of different calcium antagonists on transcapillary fluid shift. Am J Hypertens. 1990;3:491–495
  21. Markham RV, Gilmore A, Pettinger WA, et al.  Central and regional hemodynamic effects and neurohumoral consequences of minoxidil in severe congestive heart failure and comparison to hydralazine and nitroprusside. Am J Cardiol. 1983;52:774–781
  22. Mroczek WJ, Lee WR. Diazoxide therapy (use and risks). Ann Intern Med. 1976;85:529
  23. Gorson DM. Significant weight gain with Rezulin therapy. Arch Intern Med. 1999;159:99
  24. Thomas ML, Lloyd SJ. Pulmonary edema associated with rosiglitazone and troglitazone. Ann Pharmacother. 2001;35:123–124
  25. Davison JM. Edema in pregnancy. Kidney Int. 1997;51(suppl):S90–S96
  26. Valenzuela GJ. Is a decrease in plasma oncotic pressure enough to explain the edema in pregnancy?. Am J Obstet Gynecol. 1989;161:1624–1627
  27. Young JR. The swollen leg (clinical significance and differential diagnosis). Cardiol Clin. 1991;9:443–456
  28. Schirger A. DDx and management of leg edema in the elderly. Geriatrics. 1982;37:26–32
  29. Lymphatic filariasis—tropical medicine’s origin will not go away. [editorial] Lancet. 1987;1:1409–1410
  30. Szuba A, Rockson S. Lymphedema (anatomy, physiology and pathogenesis). Vasc Med. 1997;2:321–326
  31. Rockson S. Lymphedema. Am J Med. 2001;110:288–295
  32. Hierholzer K, Finke R. Myxedema. Kidney Int. 1997;51(suppl):S82–S89
  33. Goldberg M, Reivich M. Studies on the mechanism of hyponatremia and impaired water excretion in myxedema. Ann Intern Med. 1962;56:120–130
  34. Pettinger WA, Talner L, Ferris TF. Inappropriate secretion of antidiuretic hormone due to myxedema. N Engl J Med. 1965;272:362–364
  35. Chinitz A, Turner FL. The association of primary hypothyroidism and inappropriate secretion of antidiuretic hormone. Arch Intern Med. 1965;116:871–874
  36. DeRubertis FR, Michelis MF, Bloom ME, et al.  Impaired water excretion in myxedema. Am J Med. 1971;51:41–53
  37. Iwasaki Y, Oiso Y, Yamauchi K, et al.  Osmoregulation of plasma vasopressin in myxedema. J Clin Endocrinol Metab. 1990;70:534–539
  38. Kay A, Davis CL. Idiopathic edema. Am J Kidney Dis. 1999;34:405–423
  39. Thorn G. Approach to the patient with “idiopathic edema” or “periodic swelling”. JAMA. 1968;206:333–338
  40. McKendry JB. Idiopathic edema. Can Nurse. 1973;69:41–43
  41. Bates B. Examination and History Taking. Philadelphia: J.B. Lippincott; 1991;
  42. Blankfield RP, Finkelhor RS, Alexander JJ, et al.  Etiology and diagnosis of bilateral leg edema in primary care. Am J Med. 1998;105:192–197
  43. Davie AP, Love MP, McMurray JJ. Value of ECGs in identifying heart failure due to left systolic dysfunction. BMJ. 1996;313:300–301
  44. Davidson C. Can heart failure be diagnosed in primary care. Chest radiography is still useful. BMJ. 2000;321:1414–1415
  45. McDonagh TA, Robb SD, Murdoch DR, et al.  Biochemical detection of left-ventricular dysfunction. Lancet. 1998;351:9–13
  46. Talwar S, Squire IB, Davies JE, et al.  Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left ventricular systolic dysfunction in a high risk population. Eur Heart J. 1999;20:1736–1744
  47. McClure SJ, Caruana L, Davie AP, et al.  Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. BMJ. 1998;317:516–519
  48. Nielsen OW, Hansen JF, Hilden J, et al.  Risk assessment of left ventricular systolic dysfunction in primary care (cross sectional study evaluating a range of diagnostic tests). BMJ. 2000;320:220–224
  49. Dao Q, Krishnaswamy P, Kazanegra R, et al.  Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol. 2001;37:379–385
  50. Vargo DL, Kramer WG, Black PK, et al.  Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther. 1995;57:601–609
  51. Brater DC. Diuretic therapy. N Engl J Med. 1998;339:387–395
  52. Voelker JR, Cartwright-Brown D, Anderson S, et al.  Comparison of loop diuretics in patients with chronic renal insufficiency. Kidney Int. 1987;32:572–578

PII: S0002-9343(02)01322-0

The American Journal of Medicine
Volume 113, Issue 7 , Pages 580-586 , November 2002

Article Tools

* Image Usage & Resolution